Graham Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23M | Sell |
77,801
-2,231
| -3% | -$663K | 0.56% | 36 |
|
|
2025
Q4 | $21.9M | Buy |
80,032
+3,338
| +4% | +$907K | 0.52% | 40 |
|
|
2025
Q3 | $20.7M | Sell |
76,694
-10,655
| -12% | -$2.9M | 0.33% | 39 |
|
|
2025
Q2 | $24.1M | Buy |
87,349
+12,349
| +16% | +$3.36M | 0.36% | 30 |
|
|
2025
Q1 | $19.9M | Hold |
75,000
| – | – | 0.35% | 32 |
|
|
2024
Q4 | $17.4M | Sell |
75,000
-1,088
| -1% | -$250K | 0.26% | 38 |
|
|
2024
Q3 | $16.8M | Sell |
76,088
-937
| -1% | -$194K | 0.29% | 44 |
|
|
2024
Q2 | $15.1M | Buy |
77,025
+2,025
| +3% | +$418K | 0.33% | 34 |
|
|
2024
Q1 | $16.1M | Hold |
75,000
| – | – | 0.3% | 43 |
|
|
2023
Q4 | $15.8M | Sell |
75,000
-573
| -0.8% | -$122K | 0.35% | 43 |
|
|
2023
Q3 | $15.1M | Buy |
75,573
+573
| +0.8% | +$114K | 0.36% | 53 |
|
|
2023
Q2 | $13.9M | Sell |
75,000
-8
| -0% | -$1.48K | 0.4% | 39 |
|
|
2023
Q1 | $14.4M | Sell |
75,008
-14,849
| -17% | -$2.69M | 0.44% | 25 |
|
|
2022
Q4 | $15.1M | Buy |
89,857
+11,168
| +14% | +$1.94M | 0.46% | 23 |
|
|
2022
Q3 | $13.9M | Sell |
78,689
-4,208
| -5% | -$832K | 0.55% | 26 |
|
|
2022
Q2 | $17M | Buy |
82,897
+3,756
| +5% | +$796K | 0.69% | 22 |
|
|
2022
Q1 | $18.8M | Buy |
79,141
+4,141
| +6% | +$973K | 0.65% | 24 |
|
|
2021
Q4 | $17.1M | Hold |
75,000
| – | – | 0.73% | 27 |
|
|
2021
Q3 | $14.5M | Hold |
75,000
| – | – | 0.74% | 31 |
|
|
2021
Q2 | $16M | Hold |
75,000
| – | – | 0.83% | 30 |
|
|
2021
Q1 | $15.3M | Hold |
75,000
| – | – | 0.68% | 45 |
|
|
2020
Q4 | $13.7M | Hold |
75,000
| – | – | 0.5% | 47 |
|
|
2020
Q3 | $12.5M | Buy |
75,000
+45,000
| +150% | +$7.58M | 0.43% | 36 |
|
|
2020
Q2 | $4.88M | Hold |
30,000
| – | – | 0.23% | 52 |
|
|
2020
Q1 | $5.19M | Hold |
30,000
| – | – | 0.37% | 38 |
|
|
2019
Q4 | $6.02M | Hold |
30,000
| – | – | 0.22% | 58 |
|
|
2019
Q3 | $6.34M | Hold |
30,000
| – | – | 0.21% | 60 |
|
|
2019
Q2 | $5.82M | Hold |
30,000
| – | – | 0.17% | 52 |
|
|
2019
Q1 | $4.94M | Hold |
30,000
| – | – | 0.27% | 44 |
|
|
2018
Q4 | $5.64M | Hold |
30,000
| – | – | 0.25% | 37 |
|
|
2018
Q3 | $5.11M | Hold |
30,000
| – | – | 0.11% | 44 |
|
|
2018
Q2 | $4.92M | Hold |
30,000
| – | – | 0.18% | 48 |
|
|
2018
Q1 | $4.85M | Hold |
30,000
| – | – | 0.26% | 43 |
|
|
2017
Q4 | $4.38M | Hold |
30,000
| – | – | 0.11% | 37 |
|
|
2017
Q3 | $4.07M | Hold |
30,000
| – | – | 0.09% | 46 |
|
|
2017
Q2 | $3.76M | Hold |
30,000
| – | – | 0.1% | 36 |
|
|
2017
Q1 | $3.56M | Hold |
30,000
| – | – | 0.14% | 59 |
|
|
2016
Q4 | $3.46M | Hold |
30,000
| – | – | 0.14% | 39 |
|
|
2016
Q3 | $3.14M | Hold |
30,000
| – | – | 0.1% | 69 |
|
|
2016
Q2 | $2.92M | Hold |
30,000
| – | – | 0.15% | 69 |
|
|
2016
Q1 | $2.88M | Hold |
30,000
| – | – | 0.31% | 66 |
|
|
2015
Q4 | $2.72M | Hold |
30,000
| – | – | 0.5% | 34 |
|
|
2015
Q3 | $2.78M | Hold |
30,000
| – | – | 0.33% | 68 |
|
|
2015
Q2 | $2.79M | Hold |
30,000
| – | – | 0.15% | 90 |
|
|
2015
Q1 | $2.84M | Hold |
30,000
| – | – | 0.14% | 82 |
|
|
2014
Q4 | $2.66M | Sell |
30,000
-300
| -1% | -$25.4K | 0.11% | 104 |
|
|
2014
Q3 | $2.42M | Buy |
30,300
+100
| +0.3% | +$7.54K | 0.11% | 103 |
|
|
2014
Q2 | $2.14M | Sell |
30,200
-200
| -0.7% | -$14.1K | 0.06% | 112 |
|
|
2014
Q1 | $2.25M | Buy |
30,400
+300
| +1% | +$22.6K | 0.12% | 83 |
|
|
2013
Q4 | $2.36M | Sell |
30,100
-100
| -0.3% | -$7.83K | 0.13% | 74 |
|
|
2013
Q3 | $2.23M | Buy |
30,200
+100
| +0.3% | +$7.37K | 0.14% | 84 |
|
|
2013
Q2 | $2.29M | Buy |
+30,100
| New | +$1.97M | 0.15% | 54 |
|
Other funds holding CME
VCM
VPM
Graham Capital Management's CME Position: Q1 2026 in Review
Graham Capital Management reduced its CME Group (CME) stake by 2.8% in Q1 2026, selling an estimated $663K and leaving 77,801 shares worth $23M. The position accounts for 0.56% of the portfolio, ranked #36.
Graham Capital Management first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.1M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Graham Capital Management held 77,801 shares of CME Group worth $23M as of Q1 2026.
- Graham Capital Management sold 2,231 CME Group shares in Q1 2026, an estimated $663K.
- CME Group made up 0.56% of Graham Capital Management's portfolio in Q1 2026, its #36 holding.
- Graham Capital Management first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- Graham Capital Management's CME Group position peaked at $24.1M in Q2 2025.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.